About Healius Pathology India Private Limited
Data last updated:
Healius Pathology India Private Limited is a foreign private limited company based in Bangalore, Karnataka, India, a subsidiary of Hls Pathology Holding Pty Ltd. It operates in the IT consulting and support services segment of the technology and IT services sector. It was incorporated on 18 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U72200KA2007FTC042522. Its GSTIN is 29AAKCS7544N1ZG (Karnataka). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Symbion Pathology (India) Private Limited. It is led by directors Stephen James Donald Humphries and Sanjeev Kumar Ozha.
Its last annual general meeting (AGM) was held on 28 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹39.66 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹3 Cr (net margin 7.6%) and EBITDA of ₹6.08 Cr (EBITDA margin 15.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 10% over five years.
The company has about 690 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sdspathology.com.
Company details
Contact details
Healius Pathology India Private Limited's registered office is in Bangalore, Karnataka. Its website is sdspathology.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressWework Prestige Central, 36 Infantry Road, Bangalore, Karnataka, India – 560001
- IndustryInformation Technology, IT Consulting & Support Services
To see the full contact details of Healius Pathology India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Healius Pathology India is information and communication. In detail, this covers other information & communication service activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities |
To see the full business activity and turnover split of Healius Pathology India Private Limited, buy the company report.
Financials of Healius Pathology India Private Limited
FY 2025 filings availableHealius Pathology India Private Limited reported revenue of ₹39.66 Cr (up 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 15% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.08 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.3% | ||||
| Net Profit Margin | 7.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Healius Pathology India Private Limited, buy the company report.
Board of directors of Healius Pathology India Private Limited
Healius Pathology India has 2 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Stephen James Donald Humphries | Director | 10 May 2024 | 2 Years 5 Months | Current |
| Sanjeev Kumar Ozha | Additional Director | 07 Oct 2025 | 1 Years 1 Months | Current |
Peer comparison
Healius Pathology India Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (other information & communication service activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Docquity Services Private Limited | ₹39.94 Cr (FY 2024) | 5.0% | New Delhi, Delhi, India | |||
| Sampl Communications Private Limited | ₹39.8 Cr (FY 2025) | 17.0% | Delhi, India | |||
| Neuraflash India Private Limited | ₹39.75 Cr (FY 2025) | 31.0% | New Delhi, Delhi, India | |||
| Imimobile Cloud Communications (India) Private Limited | ₹39.71 Cr (FY 2024) | -49.0% | Hyderabad, Telangana, India | |||
| Healius Pathology India Private Limitedthis company | ₹39.66 Cr (FY 2024) | ₹3 Cr | 7.6% | 15.0% | 690 | Bangalore, Karnataka, India |
| Qfi Technologies Private Limited | ₹39.62 Cr (FY 2024) | 277.0% | Bengaluru, Karnataka, India | |||
| RZRG Technology Services India Private Limited | ₹39.61 Cr (FY 2024) | 10.0% | New Delhi, Delhi, India | |||
| Stratogent Technology Services Private Limited | ₹39.6 Cr (FY 2025) | 12.0% | Bangalore, Karnataka, India | |||
| Zingoy Rewards Private Limited | ₹39.59 Cr (FY 2023) | -30.0% | Mumbai, Maharashtra, India | |||
| Alpha Ori India Private Limited | ₹39.52 Cr (FY 2025) | 8.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Healius Pathology India Private Limited, buy the company report.
Auditor
Healius Pathology India Private Limited is audited by S.R. Batliboi & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. Batliboi & Associates LLP | FY 2023 | 101049W/E300004 |
Shareholding
The shareholding of Healius Pathology India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Healius Pathology India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Healius Pathology India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Healius Pathology India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Healius Pathology India Private Limited has a workforce of 690 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Healius Pathology India has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAKCS7544N1ZG | Karnataka | Active | 01 Jul 2017 |
| 36AAKCS7544N1ZL | Telangana | Active | 23 Aug 2017 |
To see the full GST registrations and return filing status of Healius Pathology India Private Limited, buy the company report.
Recent activity
Healius Pathology India Private Limited has 23 board changes on record since 2007: 3 appointments and 20 cessations. The latest: Sanjeev Kumar Ozha was appointed as Additional Director on 07 Oct 2025.
14 earlier events are in the company report.
Frequently asked questions
Healius Pathology India is an active foreign private limited company based in Bangalore, Karnataka, India. The company works in IT consulting and support services, within the information technology industry. It was incorporated on 18 April 2007 (19+ years old) and is registered under CIN U72200KA2007FTC042522.
Healius Pathology India has 2 current directors:
- Stephen James Donald Humphries - Director
- Sanjeev Kumar Ozha - Additional Director
The latest financial statements of Healius Pathology India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 November 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Healius Pathology India is 29AAKCS7544N1ZG, registered in Karnataka. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 36AAKCS7544N1ZL (Telangana).
The CIN (Corporate Identification Number) of Healius Pathology India is U72200KA2007FTC042522. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Healius Pathology India was incorporated on 18 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Healius Pathology India by revenue are Docquity Services Private Limited, Sampl Communications Private Limited, Neuraflash India Private Limited, Imimobile Cloud Communications (India) Private Limited, Qfi Technologies Private Limited and 4 more, all in the same principal business activity (other information & communication service activities).
Sanjeev Kumar Ozha was appointed as Additional Director on 07 Oct 2025. Stephen James Donald Humphries ceased to be Additional Director on 29 Nov 2024. Yusuf Shabbir Thasrawala ceased to be Additional Director on 29 Nov 2024. Healius Pathology India has 23 board changes on record in total.
Healius Pathology India can be reached through the website sdspathology.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Healius Pathology India is at Wework Prestige Central, 36 Infantry Road, Bangalore, Karnataka, India – 560001.
Healius Pathology India operates in the information technology industry, in the IT consulting and support services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
